Aby J. Mathew Biolife Solutions Inc (BLFS) insider trading activity

Aby J. Mathew is EVP & Chief Scientific Officer of BIOLIFE SOLUTIONS INC. Currently has a direct ownership of 353,118 shares of BLFS, which is worth approximately $7.59 Million. The most recent transaction as insider was on Jun 28, 2022, when has been sold 704 shares (Common Stock) at a price of $14.86 per share, resulting in proceeds of $10,461. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 353K

35.5% 3M change

10.87% 12M change

Total Value Held $7.59 Million

Aby J. Mathew Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 28 2022	SELL Open market or private sale	$10,461 $14.86 p/Share	704 Reduced 0.28%	253,015 Common Stock
Jun 19 2022	BUY Grant, award, or other acquisition	-	733 Added 0.29%	253,719 Common Stock
Jun 05 2022	BUY Grant, award, or other acquisition	-	735 Added 0.29%	252,986 Common Stock
May 27 2022	SELL Open market or private sale	$5,100 $14.53 p/Share	351 Reduced 0.14%	252,251 Common Stock
May 22 2022	BUY Grant, award, or other acquisition	-	786 Added 0.31%	252,602 Common Stock
May 13 2022	SELL Open market or private sale	$1,331 $12.32 p/Share	108 Reduced 0.04%	251,816 Common Stock
Apr 18 2022	SELL Open market or private sale	$339,927 $17.59 p/Share	19,325 Reduced 7.12%	251,924 Common Stock
Apr 12 2022	BUY Exercise of conversion of derivative security	-	45,726 Added 14.43%	271,249 Common Stock
Mar 29 2022	SELL Open market or private sale	$14,634 $22.24 p/Share	658 Reduced 0.29%	225,523 Common Stock
Mar 01 2022	SELL Open market or private sale	$9,797 $23.78 p/Share	412 Reduced 0.2%	205,152 Common Stock
Feb 24 2022	BUY Grant, award, or other acquisition	-	21,029 Added 8.49%	226,593 Common Stock
Feb 10 2022	SELL Open market or private sale	$13,221 $29.38 p/Share	450 Reduced 0.22%	205,564 Common Stock
Feb 03 2022	SELL Open market or private sale	$273,075 $27.76 p/Share	9,837 Reduced 4.56%	206,014 Common Stock
Feb 03 2022	BUY Exercise of conversion of derivative security	$20,264 $2.06 p/Share	9,837 Added 4.36%	215,851 Common Stock
Feb 02 2022	SELL Open market or private sale	$298,800 $29.88 p/Share	10,000 Reduced 4.63%	206,014 Common Stock
Feb 02 2022	BUY Exercise of conversion of derivative security	$37,000 $3.7 p/Share	10,000 Added 4.42%	216,014 Common Stock
Jan 05 2022	SELL Open market or private sale	$269,495 $34.3 p/Share	7,857 Reduced 3.67%	206,014 Common Stock
Jan 05 2022	BUY Exercise of conversion of derivative security	$11,000 $1.4 p/Share	7,857 Added 3.54%	213,871 Common Stock
Jan 04 2022	SELL Open market or private sale	$350,600 $35.06 p/Share	10,000 Reduced 4.63%	206,014 Common Stock
Jan 04 2022	BUY Exercise of conversion of derivative security	$14,000 $1.4 p/Share	10,000 Added 4.42%	216,014 Common Stock
Dec 29 2021	SELL Open market or private sale	$28,976 $39.37 p/Share	736 Reduced 0.36%	206,014 Common Stock
Dec 08 2021	SELL Open market or private sale	$323,046 $36.49 p/Share	8,853 Reduced 4.11%	206,750 Common Stock
Dec 08 2021	BUY Exercise of conversion of derivative security	$14,519 $1.64 p/Share	8,853 Added 3.94%	215,603 Common Stock
Dec 06 2021	SELL Open market or private sale	$343,900 $34.39 p/Share	10,000 Reduced 4.61%	206,750 Common Stock
Dec 06 2021	BUY Exercise of conversion of derivative security	$16,400 $1.64 p/Share	10,000 Added 4.41%	216,750 Common Stock

AJM

Aby J. Mathew

EVP & Chief Scientific Officer

Bothell, WA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLFS shares.

Notify only if

Value

Insider Trading

Get notified when an Biolife Solutions Inc insider buys or sells BLFS shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIOLIFE SOLUTIONS INC

Track Activities on BLFS

Account